Rankings
▼
Calendar
GPCR Q3 2022 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
GPCR
Structure Therapeutics Inc.
$3B
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$12M
EPS (Diluted)
$-1.27
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$11M
Stock-Based Comp.
$628,000
Balance Sheet
Total Assets
$108M
Total Liabilities
$212M
Stockholders' Equity
-$104M
Cash & Equivalents
$28M
← FY 2022
All Quarters
Q4 2022 →